Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Therapeutic and Diagnostic Antibodies, Katholieke Universiteit Leuven, Leuven, Belgium.
J Thromb Haemost. 2015 Jun;13(6):1084-9. doi: 10.1111/jth.12894. Epub 2015 Apr 6.
Thrombin-activatable fibrinolysis inhibitor (TAFI) is a zymogen that can be activated to form activated TAFI (TAFIa) (Ala93-Val401) through removal of the N-terminal activation peptide (Phe1-Arg92). TAFIa is thermally unstable, and the role of the activation peptide in the activity and stability of TAFI zymogen remains unclear.
To better understand the role of the activation peptide in the activity and stability of TAFI.
We constructed a deletion mutant, TAFI-CIIYQ-∆1-73 , in which the first 73 amino acids of the activation peptide are absent. The intrinsic activity and functional stability were determined with a chromogenic assay. The activation of TAFI-CIIYQ-∆1-73 by TAFI activators was evaluated with western blot analysis.
In comparison with TAFI-CIIYQ, the deletion mutant exerted high intrinsic activity ('full' apparent TAFIa activity) without cleavage by TAFI activators. TAFI-CIIYQ-∆1-73 was cleavable by thrombin. However, in the presence of thrombomodulin, the thrombin-mediated cleavage of TAFI-CIIYQ-∆1-73 was not accelerated. TAFI-CIIYQ-∆1-73 showed a similar functional stability profile to that of TAFI-CIIYQ. Full cleavage by thrombin did not affect the apparent carboxypeptidase activity of TAFI-CIIYQ-∆1-73 , but resulted in a significant loss of functional stability.
A stable deletion mutant of TAFI with full carboxypeptidase activity without activation is described. The segment Ala74-Arg92 in the activation peptide contributes significantly to the role of the activation peptide in stabilization of the catalytic moiety in TAFI zymogen.
凝血酶可激活纤溶抑制物(TAFI)是一种酶原,可通过去除 N 端激活肽(Phe1-Arg92)转化为激活的 TAFI(TAFIa)(Ala93-Val401)。TAFIa 热不稳定性,激活肽在 TAFI 酶原活性和稳定性中的作用尚不清楚。
更好地了解激活肽在 TAFI 酶原活性和稳定性中的作用。
构建了一个缺失突变体 TAFI-CIIYQ-∆1-73,其中缺失了激活肽的前 73 个氨基酸。通过比色法测定了其固有活性和功能稳定性。通过 Western blot 分析评估了 TAFI 激活剂对 TAFI-CIIYQ-∆1-73 的激活作用。
与 TAFI-CIIYQ 相比,缺失突变体无需 TAFI 激活剂切割即可发挥高固有活性(“完全”表观 TAFIa 活性)。TAFI-CIIYQ-∆1-73 可被凝血酶切割。然而,在血栓调节蛋白存在下,凝血酶介导的 TAFI-CIIYQ-∆1-73 切割并未加速。TAFI-CIIYQ-∆1-73 的功能稳定性与 TAFI-CIIYQ 相似。凝血酶的完全切割不影响 TAFI-CIIYQ-∆1-73 的表观羧肽酶活性,但导致功能稳定性显著丧失。
描述了一种具有完全羧肽酶活性而无需激活的 TAFI 稳定缺失突变体。激活肽中的 Ala74-Arg92 片段在激活肽稳定 TAFI 酶原催化部分中的作用中起着重要作用。